Evidence map›Paper›PMID 19234476›Full record

ReviewNature reviews. Molecular cell biology2009

Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system.

Hellmut G Augustin, Gou Young Koh, Gavin Thurston, Kari Alitalo

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Nature reviews. Molecular cell biology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02307500 (An Open-label Phase II Study of Regorafenib in Patients With Metastatic Solid Tumors Who Have Progressed After Standard Therapy - RESOUND), which is not on this map. Cited by 707 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
707citing papers in PubMed, 1 pooled it
35.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02307500 phase2completednot on this mapstarted 2014, after this paper: background citation

An Open-label Phase II Study of Regorafenib in Patients With Metastatic Solid Tumors Who Have Progressed After Standard Therapy - RESOUND

TypeinterventionalSponsorIstituto Clinico HumanitasRan2014 to 2020Enrolled82ConditionsPancreas Cancer, Ovarian Cancer, Melanoma, SarcomaArmsRegorafenib
3 · Its place in the literature

Who cites it

707 citing papers in PubMed, 1 synthesis or guideline pooled it, 1,415 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Switching to faricimab in anti-VEGF-refractory retinal vein occlusion: nine-month prospective real-world outcomes under a modified treat-and-extend regimen.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2026
    Article
  4. Article
  5. Article
  6. Gene-Specific Endothelial Programs Drive AVM Pathogenesis inArteriosclerosis, thrombosis, and vascular biology · 2026
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. ZEB1 Modifies VE-Cadherin Signaling in Lymphatic Endothelial Cells.Microcirculation (New York, N.Y. : 1994) · 2026
    Article
  19. Review
  20. Article

647 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 4 countries.

Hellmut G AugustinJoint Research Division Vascular Biology, Medical Faculty Mannheim (CBTM), University of Heidelberg, and German Cancer Research Center Heidelberg (DKFZ-ZMBH Alliance), Germany. augustin@angiogenese.de
Gou Young Koh
Gavin Thurston
Kari Alitalo
German Cancer Research Center · DEKorea Advanced Institute of Science and Technology · KRRegeneron (United States) · USUniversity of Helsinki · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Angiogenesis, the growth of blood vessels, is a fundamental biological process that controls embryonic development and is also involved in numerous life-threatening human diseases. Much work in the field of angiogenesis research has centred on the vascular endothelial growth factor (VEGF)-VEGF receptor system. The Tie receptors and their angiopoietin (Ang) ligands have been identified as the second vascular tissue-specific receptor Tyr kinase system. Ang-Tie signalling is essential during embryonic vessel assembly and maturation, and functions as a key regulator of adult vascular homeostasis. The structural characteristics and the spatio-temporal regulation of the expression of receptors and ligands provide unique insights into the functions of this vascular signalling system.

Indexed as

HomeostasisMorphogenesisAngiopoietinsAnimalsBlood VesselsHumansModels, BiologicalReceptors, TIESignal TransductionAngiopoietinsReceptors, TIE

Identifiers

PMID19234476
OpenAlexW2081596239

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.